1
|
3R measures in facilities for the production of genetically modified rodents. Lab Anim (NY) 2022; 51:162-177. [PMID: 35641635 DOI: 10.1038/s41684-022-00978-1] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/09/2021] [Accepted: 04/22/2022] [Indexed: 12/30/2022]
Abstract
Sociocultural changes in the human-animal relationship have led to increasing demands for animal welfare in biomedical research. The 3R concept is the basis for bringing this demand into practice: Replace animal experiments with alternatives where possible, Reduce the number of animals used to a scientifically justified minimum and Refine the procedure to minimize animal harm. The generation of gene-modified sentient animals such as mice and rats involves many steps that include various forms of manipulation. So far, no coherent analysis of the application of the 3Rs to gene manipulation has been performed. Here we provide guidelines from the Committee on Genetics and Breeding of Laboratory Animals of the German Society for Laboratory Animal Science to implement the 3Rs in every step during the generation of genetically modified animals. We provide recommendations for applying the 3Rs as well as success/intervention parameters for each step of the process, from experiment planning to choice of technology, harm-benefit analysis, husbandry conditions, management of genetically modified lines and actual procedures. We also discuss future challenges for animal welfare in the context of developing technologies. Taken together, we expect that our comprehensive analysis and our recommendations for the appropriate implementation of the 3Rs to technologies for genetic modifications of rodents will benefit scientists from a wide range of disciplines and will help to improve the welfare of a large number of laboratory animals worldwide.
Collapse
|
2
|
Gene delivery to Nile tilapia cells for transgenesis and the role of PI3K-c2α in angiogenesis. Sci Rep 2017; 7:44317. [PMID: 28317860 PMCID: PMC5357942 DOI: 10.1038/srep44317] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/17/2016] [Accepted: 02/06/2017] [Indexed: 01/08/2023] Open
Abstract
Microinjection is commonly performed to achieve fish transgenesis; however, due to difficulties associated with this technique, new strategies are being developed. Here we evaluate the potential of lentiviral particles to genetically modify Nile tilapia cells to achieve transgenesis using three different approaches: spermatogonial stem cell (SSC) genetic modification and transplantation (SC), in vivo transduction of gametes (GT), and fertilised egg transduction (ET). The SC protocol using larvae generates animals with sustained production of modified sperm (80% of animals with 77% maximum sperm fluorescence [MSF]), but is a time-consuming protocol (sexual maturity in Nile tilapia is achieved at 6 months of age). GT is a faster technique, but the modified gamete production is temporary (70% of animals with 52% MSF). ET is an easier way to obtain mosaic transgenic animals compared to microinjection of eggs, but non-site-directed integration in the fish genome can be a problem. In this study, PI3Kc2α gene disruption impaired development during the embryo stage and caused premature death. The manipulator should choose a technique based on the time available for transgenic obtainment and if this generation is required to be continuous or not.
Collapse
|
3
|
Park JE, Zhang XF, Choi SH, Okahara J, Sasaki E, Silva AC. Generation of transgenic marmosets expressing genetically encoded calcium indicators. Sci Rep 2016; 6:34931. [PMID: 27725685 PMCID: PMC5057151 DOI: 10.1038/srep34931] [Citation(s) in RCA: 65] [Impact Index Per Article: 8.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 09/20/2016] [Indexed: 02/04/2023] Open
Abstract
Chronic monitoring of neuronal activity in the living brain with optical imaging techniques became feasible owing to the continued development of genetically encoded calcium indicators (GECIs). Here we report for the first time the successful generation of transgenic marmosets (Callithrix jacchus), an important nonhuman primate model in neurophysiological research, which were engineered to express the green fluorescent protein (GFP)-based family of GECIs, GCaMP, under control of either the CMV or the hSyn promoter. High titer lentiviral vectors were produced, and injected into embryos collected from donor females. The infected embryos were then transferred to recipient females. Eight transgenic animals were born and shown to have stable and functional GCaMP expression in several different tissues. Germline transmission of the transgene was confirmed in embryos generated from two of the founder transgenic marmosets that reached sexual maturity. These embryos were implanted into six recipient females, three of which became pregnant and are in advanced stages of gestation. We believe these transgenic marmosets will be invaluable non-human primate models in neuroscience, allowing chronic in vivo monitoring of neural activity with functional confocal and multi-photon optical microscopy imaging of intracellular calcium dynamics.
Collapse
Affiliation(s)
- Jung Eun Park
- Cerebral Microcirculation Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | - Xian Feng Zhang
- Cerebral Microcirculation Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | - Sang-Ho Choi
- Cerebral Microcirculation Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| | - Junko Okahara
- Department of Applied Developmental Biology, Central Institute for Experimental Animals, Tonomachi, Kawasaki, Kanagawa 210-0821, Japan
| | - Erika Sasaki
- Department of Applied Developmental Biology, Central Institute for Experimental Animals, Tonomachi, Kawasaki, Kanagawa 210-0821, Japan.,Keio advanced Research Center, Keio University, Shinanomachi, Shinjuku-ku, Tokyo 160-8582, Japan
| | - Afonso C Silva
- Cerebral Microcirculation Section, Laboratory of Functional and Molecular Imaging, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA
| |
Collapse
|
4
|
Embryo development, fetal growth and postnatal phenotype of eGFP lambs generated by lentiviral transgenesis. Transgenic Res 2014; 24:31-41. [PMID: 25048992 DOI: 10.1007/s11248-014-9816-x] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2014] [Accepted: 07/11/2014] [Indexed: 10/25/2022]
Abstract
Lentiviral technology has been recently proposed to generate transgenic farm animals more efficiently and easier than traditional techniques. The objective was to evaluate several parameters of lambs obtained by lentiviral transgenesis in comparison with non-transgenic counterparts. In vitro produced embryos were microinjected (TG group) at two-cell stage with a lentiviral construct containing enhanced green fluorescent protein (eGFP) gene, while embryos produced by in vitro fertilization (IVF group) or intrauterine insemination (IUI group) were not microinjected. Microinjection technique efficiently generated eight-cell transgenic embryos (97.4%; 114/117). Development rate on day 5 after fertilization was similar for TG (39.3%, 46/117) and IVF embryos (39.6%, 44/111). Pregnancy rate was detected in 50.0% (6/12) of recipient ewes with TG embryos, in 46.7% (7/15) with IVF embryos, and in 65.0% (13/20) of IUI ewes (P = NS). Nine lambs were born in TG group, six lambs in IVF group, and 16 lambs in IUI group. All TG lambs (9/9) were GFP positive to real-time PCR and eight (88.9%) showed a strong and evident GFP expression in mucosae, eyes and keratin tissues. Fetal growth monitored every 15 day by ultrasonography did not show significant differences. Transgenic lambs neither differ in morphometric variables in comparison with non transgenic IVF lambs within 3 months after birth. Transmission of the transgene to the progeny was observed in green fluorescent embryos produced by IVF using semen from the TG founder lambs. In conclusion, this study demonstrates the high efficiency of lentiviral technology to produce transgenic sheep, with no clinic differences in comparison with non transgenic lambs.
Collapse
|
5
|
Ménoret S, Tesson L, Rémy S, Usal C, Thépenier V, Thinard R, Ouisse LH, De Cian A, Giovannangeli C, Concordet JP, Anegon I. Gene targeting in rats using transcription activator-like effector nucleases. Methods 2014; 69:102-7. [PMID: 24583114 DOI: 10.1016/j.ymeth.2014.02.027] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2013] [Revised: 02/14/2014] [Accepted: 02/20/2014] [Indexed: 02/06/2023] Open
Abstract
The rat is a model of choice to understanding gene function and modeling human diseases. Since recent years, successful engineering technologies using gene-specific nucleases have been developed to gene edit the genome of different species, including the rat. This development has become important for the creation of new rat animals models of human diseases, analyze the role of genes and express recombinant proteins. Transcription activator-like (TALE) nucleases are designed nucleases consist of a DNA binding domain fused to a nuclease domain capable of cleaving the targeted DNA. We describe a detailed protocol for generating knockout rats via microinjection of TALE nucleases into fertilized eggs. This technology is an efficient, cost- and time-effective method for creating new rat models.
Collapse
Affiliation(s)
- Séverine Ménoret
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France.
| | - Laurent Tesson
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Séverine Rémy
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Claire Usal
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Virginie Thépenier
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Reynald Thinard
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Laure-Hélène Ouisse
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| | - Anne De Cian
- INSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, 43 Rue Cuvier, F75005 Paris, France
| | - Carine Giovannangeli
- INSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, 43 Rue Cuvier, F75005 Paris, France
| | - Jean-Paul Concordet
- INSERM U565, CNRS UMR7196, Museum National d'Histoire Naturelle, 43 Rue Cuvier, F75005 Paris, France
| | - Ignacio Anegon
- Transgenic Rats Nantes IBiSA-Centre National de Recherche Scientifique, F44093 Nantes, France; ITUN, CHU Nantes, F44000 Nantes, France; INSERM UMR 1064-Center for Research in Transplantation and Immunology, France
| |
Collapse
|
6
|
Reichardt HM, Fischer HJ. Generation of Transgenic Rats Using Lentiviral Vectors. Methods Mol Biol 2014; 1304:25-37. [PMID: 25063498 DOI: 10.1007/7651_2014_107] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/16/2023]
Abstract
Transgenesis is a valuable tool with which to study different aspects of gene function in the context of the intact organism. During the last two decades a tremendous number of transgenic animals have been generated, and the continuous improvement of technology and the development of new systems have fostered their widespread application in biomedical research. Generally, transgenic animals are generated by introducing foreign DNA into fertilized oocytes, which can be achieved either by injecting recombinant DNA into the pronucleus or by transferring lentiviral particles into the perivitelline space. While mice remain the favored species in many laboratories, there are a number of applications where the use of rats is advantageous. One such research area is multiple sclerosis. Here, several experimental models are available that are closely mimicking the human disease, and it is possible to induce neuroinflammation by transferring pathogenic T cells which can then be studied by flow cytometry and 2-photon live imaging. Unlike for mice, the development of transgenic rats has encountered some hurdles in the past, e.g., due to a complicated reproductive biology and the frailty of the fertilized oocytes in vitro. In this chapter we provide a protocol describing how we manipulate single cell embryos in our lab in order to efficiently generate transgenic rats in a variety of different strains using lentiviral gene transfer.
Collapse
Affiliation(s)
- Holger M Reichardt
- Institute for Cellular and Molecular Immunology, University of Göttingen Medical School, Humboldtallee 34, Göttingen, 37073, Germany
| | | |
Collapse
|
7
|
Goulinet-Mainot S, Tranchart H, Groyer-Picard MT, Lainas P, Saloum Diop P, Holopherne D, Gonin P, Benihoud K, Ba N, Gauthier O, Franco D, Guettier C, Pariente D, Weber A, Dagher I, Huy Nguyen T. Improved Hepatocyte Engraftment After Portal Vein Occlusion in LDL Receptor-Deficient WHHL Rabbits and Lentiviral-Mediated Phenotypic Correction In Vitro. CELL MEDICINE 2012; 4:85-98. [PMID: 26858856 DOI: 10.3727/215517912x647136] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
Innovative cell-based therapies are considered as alternatives to liver transplantation. Recent progress in lentivirus-mediated hepatocyte transduction has renewed interest in cell therapy for the treatment of inherited liver diseases. However, hepatocyte transplantation is still hampered by inefficient hepatocyte engraftment. We previously showed that partial portal vein embolization (PVE) improved hepatocyte engraftment in a nonhuman primate model. We developed here an ex vivo approach based on PVE and lentiviral-mediated transduction of hepatocytes from normal (New Zealand White, NZW) and Watanabe heritable hyperlipidemic (WHHL) rabbits: the large animal model of familial hypercholesterolemia type IIa (FH). FH is a life-threatening human inherited autosomal disease caused by a mutation in the low-density lipoprotein receptor (LDLR) gene, which leads to severe hypercholesterolemia and premature coronary heart disease. Rabbit hepatocytes were isolated from the resected left liver lobe, and the portal branches of the median lobes were embolized with Histoacryl® glue under radiologic guidance. NZW and WHHL hepatocytes were each labeled with Hoechst dye or transduced with lentivirus expressing GFP under the control of a liver-specific promoter (mTTR, a modified murine transthyretin promoter) and were then immediately transplanted back into donor animals. In our conditions, 65-70% of the NZW and WHHL hepatocytes were transduced. Liver repopulation after transplantation with the Hoechst-labeled hepatocytes was 3.5 ± 2%. It was 1.4 ± 0.6% after transplantation with either the transduced NZW hepatocytes or the transduced WHHL hepatocytes, which was close to that obtained with Hoechst-labeled cells, given the mean transduction efficacy. Transgene expression persisted for at least 8 weeks posttransplantation. Transduction of WHHL hepatocytes with an LDLR-encoding vector resulted in phenotypic correction in vitro as assessed by internalization of fluorescent LDL ligands. In conclusion, our results have applications for the treatment of inherited metabolic liver diseases, such as FH, by transplantation of lentivirally transduced hepatocytes.
Collapse
Affiliation(s)
| | - Hadrien Tranchart
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital , Le Kremlin-Bicêtre , France
| | | | - Panagiotis Lainas
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital, Le Kremlin-Bicêtre, France; †Department of General Surgery, Univ. Paris-Sud, Antoine Béclère Hospital, Clamart, France
| | - Papa Saloum Diop
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital, Le Kremlin-Bicêtre, France; †Department of General Surgery, Univ. Paris-Sud, Antoine Béclère Hospital, Clamart, France
| | - Delphine Holopherne
- ‡ Department of Animal Surgery, Veterinary School of Nantes , Nantes , France
| | - Patrick Gonin
- ‡ Department of Animal Surgery, Veterinary School of Nantes , Nantes , France
| | - Karim Benihoud
- ¶ CNRS UMR 8203, Institut Gustave Roussy , Villejuif , France
| | - Nathalie Ba
- # IFR 93, Bicêtre Hospital , Le Kremlin-Bicêtre , France
| | - Olivier Gauthier
- ‡ Department of Animal Surgery, Veterinary School of Nantes , Nantes , France
| | - Dominique Franco
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital, Le Kremlin-Bicêtre, France; †Department of General Surgery, Univ. Paris-Sud, Antoine Béclère Hospital, Clamart, France
| | - Catherine Guettier
- * Department of Pathology, Bicêtre Hospital , Le Kremlin-Bicêtre , France
| | - Danièle Pariente
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital, Le Kremlin-Bicêtre, France; ††Department of Pediatric Radiology, Bicêtre Hospital, Le Kremlin-Bicêtre, France
| | - Anne Weber
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital , Le Kremlin-Bicêtre , France
| | - Ibrahim Dagher
- INSERM U 972, Univ. Paris-Sud, IFR 93, Bicêtre Hospital, Le Kremlin-Bicêtre, France; †Department of General Surgery, Univ. Paris-Sud, Antoine Béclère Hospital, Clamart, France
| | - Tuan Huy Nguyen
- ‡‡ INSERM U1064, CHU Hôtel Dieu, Université de Nantes , Nantes , France
| |
Collapse
|
8
|
Mohsin S, Siddiqi S, Collins B, Sussman MA. Empowering adult stem cells for myocardial regeneration. Circ Res 2012; 109:1415-28. [PMID: 22158649 DOI: 10.1161/circresaha.111.243071] [Citation(s) in RCA: 81] [Impact Index Per Article: 6.8] [Reference Citation Analysis] [Abstract] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Abstract
Treatment strategies for heart failure remain a high priority for ongoing research due to the profound unmet need in clinical disease coupled with lack of significant translational progress. The underlying issue is the same whether the cause is acute damage, chronic stress from disease, or aging: progressive loss of functional cardiomyocytes and diminished hemodynamic output. To stave off cardiomyocyte losses, a number of strategic approaches have been embraced in recent years involving both molecular and cellular approaches to augment myocardial structure and performance. Resultant excitement surrounding regenerative medicine in the heart has been tempered by realizations that reparative processes in the heart are insufficient to restore damaged myocardium to normal functional capacity and that cellular cardiomyoplasty is hampered by poor survival, proliferation, engraftment, and differentiation of the donated population. To overcome these limitations, a combination of molecular and cellular approaches must be adopted involving use of genetic engineering to enhance resistance to cell death and increase regenerative capacity. This review highlights biological properties of approached to potentiate stem cell-mediated regeneration to promote enhanced myocardial regeneration, persistence of donated cells, and long-lasting tissue repair. Optimizing cell delivery and harnessing the power of survival signaling cascades for ex vivo genetic modification of stem cells before reintroduction into the patient will be critical to enhance the efficacy of cellular cardiomyoplasty. Once this goal is achieved, then cell-based therapy has great promise for treatment of heart failure to combat the loss of cardiac structure and function associated with acute damage, chronic disease, or aging.
Collapse
|
9
|
Using Lentiviral Vectors as Delivery Vehicles for Gene Therapy. CONTROLLED GENETIC MANIPULATIONS 2012. [DOI: 10.1007/978-1-61779-533-6_4] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
|
10
|
Ménoret S, Tesson L, Remy S, Usal C, Iscache AL, Thynard R, Nguyen TH, Anegon I. Transgenesis and genome analysis, Nantes, France, June 6th 2011. Transgenic Res 2011. [PMCID: PMC7101805 DOI: 10.1007/s11248-011-9541-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
Affiliation(s)
- Séverine Ménoret
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- CNRS, Nantes, France
| | - Laurent Tesson
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- INSERM UMR 643, 44093 Nantes, France
| | - Séverine Remy
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- INSERM UMR 643, 44093 Nantes, France
| | - Claire Usal
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- INSERM UMR 643, 44093 Nantes, France
| | - Anne-Laure Iscache
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- INSERM UMR 643, 44093 Nantes, France
| | - Reynald Thynard
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- INSERM UMR 643, 44093 Nantes, France
| | | | - Ignacio Anegon
- Platform Transgenic Rats Nantes IBiSA, Nantes, France
- CHU Nantes, Nantes, France
- Université de Nantes, Nantes, France
- CNRS, Nantes, France
| |
Collapse
|
11
|
Cwerman-Thibault H, Sahel JA, Corral-Debrinski M. Mitochondrial medicine: to a new era of gene therapy for mitochondrial DNA mutations. J Inherit Metab Dis 2011; 34:327-44. [PMID: 20571866 DOI: 10.1007/s10545-010-9131-5] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/25/2010] [Revised: 05/12/2010] [Accepted: 05/17/2010] [Indexed: 01/01/2023]
Abstract
Mitochondrial disorders can no longer be ignored in most medical disciplines. Such disorders include specific and widespread organ involvement, with tissue degeneration or tumor formation. Primary or secondary actors, mitochondrial dysfunctions also play a role in the aging process. Despite progresses made in identification of their molecular bases, nearly everything remains to be done as regards therapy. Research dealing with mitochondrial physiology and pathology has >20 years of history around the world. We are involved, as are many other laboratories, in the challenge of finding ways to fight these diseases. However, our main limitation is the scarcety of animal models required for both understanding the molecular mechanisms underlying the diseases and evaluating therapeutic strategies. This is especially true for diseases due to mutations in mitochondrial DNA (mtDNA), since an authentic genetic model of mtDNA mutations is technically a very difficult task due to both the inability of manipulating the mitochondrial genome of living mammalian cells and to its multicopy nature. This has led researchers in the field to consider the prospect of gene therapy approaches that can roughly be divided into three groups: (1) import of wild-type copies or relevant sections of DNA or RNA into mitochondria, (2) manipulation of mitochondrial genetic content, and (3) rescue of a defect by expression of an engineered gene product from the nucleus (allotopic or xenotropic expression). We briefly introduce these concepts and indicate where promising progress has been made in the last decade.
Collapse
|
12
|
Ménoret S, Tesson L, Remy S, Usal C, Iscache AL, Anegon I. "Transgenesis, recent technical developments and applications" Nantes, 8th June 2009. Transgenic Res 2009; 19:711-4. [PMID: 19882223 DOI: 10.1007/s11248-009-9340-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2009] [Accepted: 10/15/2009] [Indexed: 11/24/2022]
Affiliation(s)
- Séverine Ménoret
- Plate-Forme Transgenese Rat IBiSA-CNRS, 30 Bd Jean Monnet, 44093, Nantes, France.
| | | | | | | | | | | |
Collapse
|
13
|
Zinc-finger nucleases: a powerful tool for genetic engineering of animals. Transgenic Res 2009; 19:363-71. [DOI: 10.1007/s11248-009-9323-7] [Citation(s) in RCA: 61] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/13/2009] [Accepted: 09/10/2009] [Indexed: 10/20/2022]
|